Recipelist

Alvegesic Vet 10 mg/ml 10 ml

Disclaimer: Product in the photo may differ from the actual product.

Nr.
10404
Brand:
VMD
Batch:
24052370
Expiry date:
31-08-2027
Registration number:
NL: REG NL 101772 UDD - BE: VE-V340575

Is the registration number of your country not listed? Then this product falls within the cascade control system. For more information, click here (please check the rules of your country, they may deviate).

Solution for injection for horses, dogs and cats

HORSE

As analgesic: for the management of moderate to severe abdominal pain (relieves abdominal pain associated with colic that is of gastrointestinal origin).

As a sedative: for sedation after administration of certain alpha-2-adrenoceptor agonists (detomidine, romifidine).

Instructions for use

Solution for intravenous use (IV). To ensure correct dosing, body weight should be determined as accurately as possible.

For analgesia
The analgesic effect is observed within 15 minutes after injection and persists for about 2 hours.

 

Route of administration Dose of butorphanol mg/kg body weight Dosis Alvegesic vet. 10 mg/ml ml/kg body weight Note
IV 0,10 0,01 ml The dose may be repeated after 3-4 hours. Treatment should not exceed 48 hours. 

Active ingredient: butorphanol 10 mg/ml (equivalent to butorphanol tartrate 14,58 mg).

Additional ingredients: Benzethonium chloride 0,10 mg/ml, Citric acid monohydrate, Sodium citrate, Sodium chloride, Water for injection.

Veterinary advice

Combination butorphanol/detomidine hydrochloride:

  • Not safe for the treatment of mares during gestation.
  • Do not use in horses with pre-existing cardiac arrhythmia or bradycardia.
  • The combination causes a decrease in gastrointestinal motility and should therefore not be used in cases of colic caused by impaction.
  • Due to a possible negative effect on the respiratory system, the veterinary medicine is contraindicated for use in horses with emphysema.

Combination butorphanol/romifidine:

  • This combination should not be used during the last month of gestation.

Use of the veterinary medicinal product at the recommended dosage may cause transient ataxia and/or excitation. Therefore, the place of treatment should be carefully chosen to avoid injuries to patient and persons during equine treatment.

Downloads

SPC (NL)

© 2024 Grovet B.V. All rights reserved.